semaglutide faa medical FDA approves obesity drug that helped people cut weight 15% FDA crackdown on off-brand Ozempic

10.1016/j.ejphar.2007.05.072 93 Tlak GajgerI.RibariJ.Smodi kerlM.VlainiJ.SikiriP

Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): A two year multicenter randomized double-blind placebo-controlled trial (ALADIN II)

Hi Aaron, I enjoyed reading your post that brings much needed attention to the Nrf2 Cell Defense Pathway

For people with type 2 diabetes who are also taking insulin or sulfonylureas, there is an increased risk of hypoglycaemia (low blood sugar)

However, effective Jan

As an exploratory pilot study, we are approaching the project with scientific curiosity rather than defined outcomes